Medline, Inc. MDLN Number of amendments
Number of amendments at other companies
Other financials
Where this comes from
Reported directly by Medline, Inc. in its filing.
Tagged under the XBRL concept mdln:DebtInstrumentsNumberOfAmendments.
The source filing: Medline, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0002046386-26-000051
During 2024, the Credit Agreement underwent three separate amendments. These amendments resulted in an increase of $520 million in the principal amount of the Dollar Term Loans, as well as an increase of €185 million in the aggregate principal amount of the Euro Term Loans. In addition, pursuant to the amendments, the applicable interest rate margins were lowered, resulting in a variable interest rate of Secured Overnight Financing Rate (“SOFR”) plus a spread of 2.25% for the Dollar Term Loans, and a variable interest rate of EURO Interbank offer Rate plus an applicable spread ranging from 2.25% to 2.75% based on certain of the Company’s debt ratios for the Euro Term Loans.
Item 1 - Financial Statements
FAQ
- What is Medline, Inc.'s number of amendments?
- Medline, Inc. (MDLN) reported number of amendments of $0.75 in Q4 2024.
- What does number of amendments mean?
- Number of amendments as reported by Medline Inc. Class A common stock.
Ask your AI about Medline, Inc.'s number of amendments.
Connect your AI assistant and compare it to peers, right in your chat.
